016360:KRXSamsung Securities Co., Ltd. Analysis
Data as of 2026-06-14 - not real-time
₩118,800.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Samsung Securities trades at 118,800 KRW, comfortably above its 200‑day SMA (≈90,352) and the 50‑day SMA (≈115,894) but just shy of the 20‑day SMA (≈120,505), indicating a short‑term pull‑back within a broader bullish framework. The 20‑day RSI sits at 49.8, suggesting neutral momentum, while the MACD histogram remains deep in negative territory (≈‑1,466) and the signal line is bearish, pointing to downward pressure on the near‑term. The stock is perched near a strong support zone at 106,500 KRW and faces resistance around 135,600 KRW, offering a clear upside potential of roughly 31 % to the consensus target of 156,077 KRW. Volume trends are stable, supporting the current price action without signs of sudden liquidity strain. Volatility over the past 30 days exceeds 100 %, and a beta of ~0.95 ties its price movements closely to the Korean market, reinforcing the need for cautious positioning. The overall technical outlook is bullish on the longer horizon but mixed in the short term due to bearish MACD divergence.
Fundamentally, the company appears markedly undervalued with a forward P/E of 7.55 versus an industry average of 16.83, and a price‑to‑sales multiple under 0.7. Revenue has surged by 129 % year‑over‑year, delivering an exceptional gross margin of 97.6 % and an operating margin of 28.5 %, which underscores a highly efficient cost structure. Profit margin stands at 7.7 % and ROE at 15.7 %, indicating solid profitability despite the heavy leverage. The balance sheet is heavily weighted by debt, with a debt‑to‑equity ratio above 400 %, and operating cash flow is negative, raising concerns about long‑term financial flexibility. Nonetheless, the dividend yield of 3.37 % on a modest 29.5 % payout, combined with ample cash reserves, provides a cushion for shareholders. The Fear & Greed Index sits at 89.86 (Extreme Greed), reflecting bullish market sentiment that could further propel the stock toward its upside. While dividend sustainability is questionable given the cash flow profile, the low payout ratio and strong cash base mitigate immediate risk. In sum, the blend of attractive valuation, robust earnings growth, and sizable upside makes the stock a compelling buy for medium‑term investors, while short‑term traders may opt to hold pending clearer technical confirmation.
Fundamentally, the company appears markedly undervalued with a forward P/E of 7.55 versus an industry average of 16.83, and a price‑to‑sales multiple under 0.7. Revenue has surged by 129 % year‑over‑year, delivering an exceptional gross margin of 97.6 % and an operating margin of 28.5 %, which underscores a highly efficient cost structure. Profit margin stands at 7.7 % and ROE at 15.7 %, indicating solid profitability despite the heavy leverage. The balance sheet is heavily weighted by debt, with a debt‑to‑equity ratio above 400 %, and operating cash flow is negative, raising concerns about long‑term financial flexibility. Nonetheless, the dividend yield of 3.37 % on a modest 29.5 % payout, combined with ample cash reserves, provides a cushion for shareholders. The Fear & Greed Index sits at 89.86 (Extreme Greed), reflecting bullish market sentiment that could further propel the stock toward its upside. While dividend sustainability is questionable given the cash flow profile, the low payout ratio and strong cash base mitigate immediate risk. In sum, the blend of attractive valuation, robust earnings growth, and sizable upside makes the stock a compelling buy for medium‑term investors, while short‑term traders may opt to hold pending clearer technical confirmation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below 20‑day SMA
- bearish MACD histogram
- neutral RSI around 50
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- forward P/E well below industry average
- strong revenue growth and high margins
- attractive dividend yield with modest payout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- sustained earnings potential in capital markets
- high leverage and negative operating cash flow risk
- potential upside to target price and favorable market sentiment
Key Metrics & Analysis
Financial Health
Revenue Growth129.20%
Profit Margin7.71%
P/E Ratio7.6
ROE15.68%
ROA1.51%
Debt/Equity410.09
Op. Cash Flow₩-4947534938112
Industry P/E16.8
Technical Analysis
TrendBullish
RSI49.8
Support₩106,500.00
Resistance₩135,600.00
MA 20₩120,505.00
MA 50₩115,894.00
MA 200₩90,351.75
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Target Price₩156,076.92
Upside/Downside31.38%
GradeUndervalued
TypeBlend
Dividend Yield3.37%
Risk Assessment
Beta0.95
Volatility103.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.